Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 263251-78-1
2. Mim-d3
3. 3-((4s,7s,10s)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2h-benzo[b][1]oxa[5,8,11]triazacyclotetradecin-10-yl)propanoic Acid
4. Nmg938vj6t
5. Tavilermide [inn]
6. Tavilermide [usan]
7. Tavilermide [who-dd]
8. Chembl3544981
9. Schembl15468298
10. Dtxsid00180937
11. Cs-7495
12. Db12441
13. Hy-17622
14. Q21098996
15. (4s,7s,10s)-2,5,8-trioxo-7-(4-aminobutyl)-10-[(carboxymethyl)carbamoyl]-17-nitro-13-oxa-3,6,9-triazabicyclo[12.4.0]octadecane-1(14),15,17-triene-4-propionic Acid
16. 3-(4r,7s,10s)-7-(4-aminobutyl)-4-((carboxymethyl)amino)carbonyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2h-1,5,8,11-benzoxatriazacyclotetradecin-10-yl) Propanoic Acid
17. 3-[(5s,8s,11s)-8-(4-aminobutyl)-5-(carboxymethylcarbamoyl)-16-nitro-7,10,13-trioxo-2-oxa-6,9,12-triazabicyclo[12.4.0]octadeca-1(14),15,17-trien-11-yl]propanoic Acid
18. D3
19. Glycine, N-(2-hydroxy-5-nitrobenzoyl)-l-.alpha.-glutamyl-l-lysyl-l-homoseryl-, Cyclic (1->3)-ether
| Molecular Weight | 580.5 g/mol |
|---|---|
| Molecular Formula | C24H32N6O11 |
| XLogP3 | -3.4 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 10 |
| Exact Mass | 580.21290586 g/mol |
| Monoisotopic Mass | 580.21290586 g/mol |
| Topological Polar Surface Area | 272 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 988 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
56
PharmaCompass offers a list of Tavilermide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tavilermide manufacturer or Tavilermide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tavilermide manufacturer or Tavilermide supplier.
PharmaCompass also assists you with knowing the Tavilermide API Price utilized in the formulation of products. Tavilermide API Price is not always fixed or binding as the Tavilermide Price is obtained through a variety of data sources. The Tavilermide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tavilermide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tavilermide, including repackagers and relabelers. The FDA regulates Tavilermide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tavilermide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tavilermide supplier is an individual or a company that provides Tavilermide active pharmaceutical ingredient (API) or Tavilermide finished formulations upon request. The Tavilermide suppliers may include Tavilermide API manufacturers, exporters, distributors and traders.
Tavilermide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tavilermide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tavilermide GMP manufacturer or Tavilermide GMP API supplier for your needs.
A Tavilermide CoA (Certificate of Analysis) is a formal document that attests to Tavilermide's compliance with Tavilermide specifications and serves as a tool for batch-level quality control.
Tavilermide CoA mostly includes findings from lab analyses of a specific batch. For each Tavilermide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tavilermide may be tested according to a variety of international standards, such as European Pharmacopoeia (Tavilermide EP), Tavilermide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tavilermide USP).
